Gentec Medical Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 21 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -50.77%
- Profit Growth -100.77%
- Ebitda -49.39%
- Net Worth -0.05%
- Total Assets -68.59%
About Gentec Medical
Gentec Medical Private Limited (GMPL) is a Private Limited Indian Non-Government Company incorporated in India on 03 September 2003 and has a history of 21 years and five months. Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Rafi Parveez and Hajeera Khatoon serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U05190KA2003PTC032493
-
Company No.
032493
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
03 Sep 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
What products or services does Gentec Medical Private Limited offer?
Gentec Medical Private Limited offers a wide range of products and services, including Surgical & ICU Equipments, ICU Equipments, Suction Machine, Diagnostic Medical Imaging Equipment, Doppler Machine, Medical Pumps, Urological & Obstetrics Instruments, Gynaecological Equipment, Nebulizer Machine & Parts, Air Compressors.
Who are the key members and board of directors at Gentec Medical?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rafi Parveez
|
Director | 03-Sep-2003 | Current |
|
Hajeera Khatoon
|
Director | 03-Sep-2003 | Current |
Financial Performance of Gentec Medical.
Gentec Medical Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 50.77% decrease. The company also saw a substantial fall in profitability, with a 100.77% decrease in profit. The company's net worth dipped by a decrease of 0.05%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Gentec Medical?
In 2023, Gentec Medical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Gentec Medical?
Unlock and access historical data on people associated with Gentec Medical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Gentec Medical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Gentec Medical's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
